BioInformant

Your Global Leader in Stem Cell Market Research

  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • News
    • Interviews
  • Advertise
  • Shop
  • Company
    • Story
    • Testimonials
    • Submit PR
    • Job Posts
    • Privacy Policy
    • Guarantee
    • Contact
Home » Products » Global Database of CAR-T Cell Therapy Companies, 2020
Database of CAR-T Cell Therapy Companies (2018) - BioInformant

Global Database of CAR-T Cell Therapy Companies, 2020

Category: Stem Cell Market Research Tag: CAR-T
  • Description

Description

Do you know the identities of 100+ CAR-T cell therapy companies worldwide?

CAR-T companies are on the rise, supported by growing investment flowing into CAR-T product development and landmark approvals of CAR-T cell therapies by the U.S. FDA, European Medicines Agency (EMA), Health Canada, Australian TGA, and others. There have also been major acquisitions within the CAR-T space, with Celgene snagging Juno Therapeutics for a shocking $9 billion in and Gilead acquiring Kite Pharma for an astounding $11.9 billion.

The Gold Standard for T Cell Cryopreservation - CryoStor, cGMP Cell Freeze Media

This is a global database of CAR-T companies that we originally developed for our own purposes.

Because more and more of our readers have been requesting access to this comprehensive list of CAR-T cell therapy companies, we are making it accessible to the public – for a limited-time only.

Features of the CAR-T Company Database (100+ Companies)

Chimeric antigen receptors (CARs) are genetically engineered allogeneic cells that are developed in the laboratory and infused into a patient, to help in detecting and fighting cancer cells. The protein constructs stimulate anti-cancer T-cells which in turn boost a patient’s immune system.

The database features the following information for 100+ CAR-T market competitors:

  • Company Name
  • CAR-T Technology
  • Disease Targets
  • Description of CAR-T Involvement
  • Country
  • City / State
  • Link to CAR-T Programs
  • Company Website

Use this list of CAR-T companies to:

  1. Identify global competitors within the CAR-T marketplace
  2. Quantify CAR-T products in late-stage development
  3. Reveal preclinical & clinical programs supporting CAR-T development
  4. Identify regions that are “hotspots” for CAR-T cell therapies
  5. Understand partnerships and co-development programs for CAR-T technologies
  6. Identify M&A activity within the CAR-T industry

Database of CAR-T Cell Therapy Companies

It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires translating company sites and clinical trial programs from dozens of languages.

Thankfully, we have a talented and multilingual team who is up to the task of listing all known CAR-T cell therapy companies worldwide.

Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident it will be an invaluable resource to your group.

Summary

With the value of recent CAR-T IPO’s nearing $1.5 billion, CAR-T financing rounds aprpoaching $2 billion, and $20 billion of market capitalization from CAR-T companies in recent years, this is clearly a hot market segment.

Would you benefit from knowing the identities of CAR-T market competitors worldwide, as well as being informed about historic CAR-T funding events?

If so, you can claim this CAR-T database for only $49 and get the CAR-T Funding Brief for FREE (a $49 value).

CAR-T Database

Act now and both products will immediately be available for download, with printing rights allowed.

Of course, your investment is backed by our 60-Day Money Back Guarantee.

If you’ve claimed this database in the past 12 months, email [email protected] to receive a free update of it.

4.9 / 5 ( 142 votes )

$49

Related products

  • Sale! List of Stem Cell Treatment Centers

    Database of Stem Cell Treatment Providers (425+ Clinics)

    $197 $97
    Add to cart
  • Sale! RMAT Designation

    Database of U.S. FDA RMAT Designations (31 Publicly Announced)

    $49 $37
    Add to cart
  • Cell and Gene Therapy CMOs

    Database of Cell and Gene Therapy CMOs / CDMOs

    $49
    Add to cart
  • Market for Stem Cell Exosomes

    The Market for Stem Cell Exosomes

    $3,495
    Add to cart

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Aspire

Marathon Products

Cellevate

Perinatal Stem cell Society

Menu
  • Blog
  • News
  • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected $197
  • Global Database of Stem Cell Therapy Companies - Featuring 100+ Companies $39
  • Defining the Future of the Stem Cell Industry: Interviews with Stem Cell Executives $197 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Disclaimer

Copyright © 2019 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.